Search Orphan Drug Designations and Approvals
-
Generic Name: | neihulizumab |
---|---|
Date Designated: | 01/25/2018 |
Orphan Designation: | Treatment of acute graft-versus-host disease (aGvHD) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AltruBio Inc. (formerly AbGenomics International, Inc.) 5050 El Camino Real Suite #105 Los Altos, California 94022 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-